KARA REYNOLDS: Open Payments
NPI 1669775672 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 12 payments from 10 companies in 2025. Trend: 2023 $60 · 2024 $37 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 1 | $32 |
| GENZYME CORPORATION | 1 | $32 |
| ABBVIE INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: Sucraid, REZDIFFRA, DUPIXENT, RINVOQ, ENTYVIO, TREMFYA, PILLCAM, Wegovy.
Industry payments across CO — which companies pay providers there.
